The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia

Amit Mahipal, Mark Weiss

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)352-354
Number of pages3
JournalCurrent oncology reports
Volume12
Issue number6
DOIs
StatePublished - Nov 1 2010

ASJC Scopus subject areas

  • Oncology

Cite this